NNNN$3.565.87%0.1973
Anbio Biotechnology (NNNN)
Date: 2026-11-02 16:00O: 3.50H: 3.73L: 3.44C: 3.56Vol: 44.48k
Anbio Biotechnology stock is traded at $3.56, with a volume of 54,368. It is up +5.87% in the last 24 hours and down -35.90% over the past month. Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Previous Close:
$3.36
Open:
$3.50
24h Volume:
54,368
Relative Volume:
0.85
Market Cap:
$156.13M
Revenue:
$9.74M
Net Income/Loss:
$7.19M
P/E Ratio:
21.73
EPS:
$0.1637
Net Cash Flow:
$2.25M
1W Performance:
-3.86%
1M Performance:
-35.90%
6M Performance:
-87.69%
1Y Performance:
-78.89%
1-Day Range:
$3.44$3.73
1-Week Range:
$3.33$3.89
52-Week Range:
$3.09$44.73
Anbio Biotechnology Stock (NNNN) Company Profile
Compare NNNN vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
NNNN Anbio Biotechnology | $156.13M | $9.74M | $7.19M | $2.25M | $0.1637 |
 ISRG Intuitive Surgical Inc | $154.74B | $11.58B | $2.96B | $3.22B | $8.73 |
 BDX Becton Dickinson Co | $54.23B | $20.84B | $941.00M | $3.07B | $3.94 |
 ALC Alcon Inc | $35.58B | $224.23M | -$39.99M | $1.59B | $1.66 |
 RMD Resmed Inc | $32.67B | $5.73B | $1.59B | $1.74B | $10.37 |
 MDLN Medline Inc | $29.56B | $29.14B | $1.07B | $1.05B | $1.20 |
